Lymphoplasmacytic Lymphoma — Trials

Lymphoplasmacytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

347 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 73
Recruiting: 33
Ph III recruiting: 2
Growth YoY: —
Industry share: 33%
Top sponsor: City of Hope Medical Center
Termination share: 28.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07592481	Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors(HEMO-CONNECT)	not yet recruiting	N/A	40	Centre Hospitalier de la côte BasqueOTHER	0	Jun 22, 2026	clinicaltrials
NCT06942507	Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia(BRZ-WM)	not yet recruiting	N/A	104	Peking Union Medical College HospitalOTHER